Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - Cerevel Therapeutics Holdings, Inc. | nt10009663x3_ex99-1.htm |
EX-23.1 - EXHIBIT 23.1 - Cerevel Therapeutics Holdings, Inc. | nt10009663x3_ex23-1.htm |
S-1 - S-1 - Cerevel Therapeutics Holdings, Inc. | nt10009663x3_s1.htm |
Exhibit 99.2
CONSENT OF TODD WIDER
ARYA Sciences Acquisition Corp II (the “Company”) intends to file a Registration Statement on Form S-1(together with any amendments or supplements thereto, the “Registration Statement”)
registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.
May 18, 2020
By:
|
/s/ Todd Wider
|
|
Name: Todd Wider
|